Signal active
Organization
Contact Information
Overview
we dedicated exclusively to providing innovative clinical nutrition products. Our products are administered under medical supervision and are intended for patients who require specialized dietary therapies. We are committed to changing the way people, who require clinical nutrition, experience their diet.
About
Biotechnology, Health Care, Pharmaceutical, Fitness, Therapeutics, Nutrition
2000
101-250
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Cambrooke Therapeutics headquartered in United States, North America, operates in the Biotechnology, Health Care, Pharmaceutical, Fitness, Therapeutics, Nutrition sector. The company focuses on Biotechnology and has secured $739.8M in funding across 72 round(s). With a team of 101-250 employees, Cambrooke Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Venture Round - Cambrooke Therapeutics, raised $10.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
3
0
0
$10.3M
Details
1
Cambrooke Therapeutics has raised a total of $10.3M in funding over 1 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2016 | Late Stage Venture |
Investors
Cambrooke Therapeutics is funded by 5 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Seventure Partners | - | FUNDING ROUND - Seventure Partners | undefined |
Galen Partners | - | FUNDING ROUND - Galen Partners | undefined |
Cambrooke Therapeutics | - | FUNDING ROUND - Cambrooke Therapeutics | undefined |
Ruffena Capital | - | FUNDING ROUND - Ruffena Capital | undefined |
Recent Activity
There is no recent news or activity for this profile.